Live Breaking News & Updates on Spruce Biosciences|Page 6
Stay updated with breaking news from Spruce biosciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spruce Biosciences, Inc. announced completion of enrollment in its CAHmelia-204 clinical trial of tildacerfont for the treatment of adult classic congenital adrenal hyperplasia . CAHmelia-204 is a. ....
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives Consensus Recommendation of "Buy" from Analysts tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Spruce Biosciences, Inc. (NASDAQ:SPRB) Receives $7.67 Consensus Target Price from Brokerages etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Spruce Biosciences, Inc. (NASDAQ:SPRB – Get Free Report) shares dropped 4.8% during mid-day trading on Monday . The stock traded as low as $2.50 and last traded at $2.80. Approximately 213,448 shares changed hands during mid-day trading, a decline of 6% from the average daily volume of 226,250 shares. The stock had previously closed at […] ....